1. 1. Sume GE, Fouda AAB, Kobela M, Nguelé S, Emah I, Atem P, et al. Epidemiology and clinical characteristics of the Measles outbreak in the Nylon Health District, Douala Cameroon: A retrospective descriptive cross-sectional study. Pan Afr Med J 2012;13:66. PMID: 23346280.
2. 2. Measles vaccines: WHO position paper – April 2017. Releve Epidemiol Hebd. 2017;92(17):205–227. PMID: 28459148.
3. 3. Deivanayagam N, Vasudevan S, Krishnamurthy PV, Shankar VJ, Ashok TP, Nedunchelian K, et al. Prevalence of placentally transmitted antibodies for measles in infants 3 – 11 months old in an urban slum community. Indian Pediatr 1990;27(9):919–923. PMID: 2286435.
4. 4. Vaidya SR, Kasibhatla SM, Bhattad DR, Ramtirthkar MR, Kale MM, Raut CG, et al. Characterization of the diversity of measles viruses in India: Genomic sequencing and comparative genomics studies. J Infect 2020;80:301–309. DOI: 10.1016/j.jinf.2019.11.025.
5. 5. Winter AK, Lambert B, Klein D, Klepac P, Papadopoulos T, Truelove S, et al. Feasibility of measles and rubella vaccination programmes for disease elimination: A modelling study. Lancet Glob Health 2022;10(10):e1412–e1422. DOI: 10.1016/S2214-109X(22)00335-7.